1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Pharmaceutical Analysis & Statistics in Oceania Countries, July 2013 (p8)

Pharmaceutical Analysis & Statistics in Oceania Countries, July 2013 (p8)

211-228 of about 200 reports

Purchase Reports From Reputable Market Research Publishers

Emergency Contraception in New Zealand

Emergency Contraception in New Zealand

  • $ 992
  • Industry report
  • July 2013
  • by Euromonitor International

Emergency contraception continued to be an acceptable medical method of preventing pregnancy within New Zealand during 2012. While abortion services are provided for free within New Zealand for permanent ...

  • Industries : OTC
  • Countries : New Zealand
OTC Triptans in New Zealand

OTC Triptans in New Zealand

  • $ 992
  • Industry report
  • July 2013
  • by Euromonitor International

During 2012 there were only two OTC triptan products available in New Zealand, Sumagran Active (Mylan New Zealand) and Zomig (AstraZeneca). Several other prescription products were available, such as Maxalt ...

  • Industries : OTC
  • Countries : New Zealand
Go Healthy New Zealand Ltd in Consumer Health (New Zealand)

Go Healthy New Zealand Ltd in Consumer Health (New Zealand)

  • $ 143
  • Company report
  • July 2013
  • by Euromonitor International

Go Healthy New Zealand is interested in providing quality vitamins and dietary supplements to New Zealand consumers. The company also focuses on introducing innovative products that suit consumer needs. ...

  • Industries : OTC, Healthcare
  • Countries : New Zealand
Douglas Pharmaceuticals Ltd in Consumer Health (New Zealand)

Douglas Pharmaceuticals Ltd in Consumer Health (New Zealand)

  • $ 143
  • Company report
  • July 2013
  • by Euromonitor International

By focusing on low-volume high-value products, Douglas Pharmaceuticals continues to attract consumers and expand its operations. Douglas Pharmaceuticals focuses on generic as well as difficult to manufacture ...

  • Industries : Pharmaceutical
  • Countries : New Zealand
Mylan New Zealand Ltd in Consumer Health (New Zealand)

Mylan New Zealand Ltd in Consumer Health (New Zealand)

  • $ 143
  • Company report
  • July 2013
  • by Euromonitor International

Over the forecast period Mylan New Zealand Ltd will focus on its core business of manufacturing and distributing pharmaceutical prescription and OTC consumer health products. Euromonitor International ...

  • Industries : Pharmaceutical, Healthcare
  • Countries : New Zealand
ICT budget forecasts in Small New Zealand Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

ICT budget forecasts in Small New Zealand Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

  • $ 495
  • Industry report
  • July 2013
  • by Kable

Synopsis This report illustrates how Kable expects Small New Zealand Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT ...

  • Industries : Pharmaceutical
  • Countries : New Zealand
ICT budget forecasts in Medium-sized New Zealand Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

ICT budget forecasts in Medium-sized New Zealand Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

  • $ 495
  • Industry report
  • July 2013
  • by Kable

Synopsis This report illustrates how Kable expects Medium-sized New Zealand Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, ...

  • Industries : Pharmaceutical
  • Countries : New Zealand
ICT budget forecasts in Large New Zealand Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

ICT budget forecasts in Large New Zealand Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

  • $ 495
  • Industry report
  • July 2013
  • by Kable

Synopsis This report illustrates how Kable expects Large New Zealand Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT ...

  • Industries : Pharmaceutical
  • Countries : New Zealand
ICT budget forecasts in Small Australian Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

ICT budget forecasts in Small Australian Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

  • $ 495
  • Industry report
  • July 2013
  • by Kable

Synopsis This report illustrates how Kable expects Small Australian Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, ...

  • Industries : Pharmaceutical
  • Countries : Australia
ICT budget forecasts in Large Australian Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

ICT budget forecasts in Large Australian Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

  • $ 495
  • Industry report
  • July 2013
  • by Kable

Synopsis This report illustrates how Kable expects Large Australian Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, ...

  • Industries : Pharmaceutical
  • Countries : Australia
ICT budget forecasts in Medium-sized Australian Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

ICT budget forecasts in Medium-sized Australian Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

  • $ 495
  • Industry report
  • July 2013
  • by Kable

Synopsis This report illustrates how Kable expects Medium-sized Australian Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, ...

  • Industries : Pharmaceutical
  • Countries : Australia
Australian Pharmaceutical Industries Ltd in Retailing (Australia)

Australian Pharmaceutical Industries Ltd in Retailing (Australia)

  • $ 143
  • Company report
  • July 2013
  • by Euromonitor International

Australian Pharmaceutical Industries Ltd is planning for rapid expansion in Australia, with the aim of opening at least 400 Priceline stores by 2014. This target amounts to an expansion of up to 50% from ...

  • Industries : Pharmaceutical
  • Countries : Australia
Pharmacybrands Ltd in Retailing (New Zealand)

Pharmacybrands Ltd in Retailing (New Zealand)

  • $ 143
  • Company report
  • May 2013
  • by Euromonitor International

Pharmacybrands is expected to continue expanding its network of chemists/pharmacies across New Zealand through its five fascias; Amcal, Care Chemist, Radius Pharmacy, Life Pharmacy and Unichem. The company ...

  • Industries : Pharmacies and Drug Stores
  • Countries : New Zealand
De Jour Sanitary Products in Tissue and Hygiene (Australia)

De Jour Sanitary Products in Tissue and Hygiene (Australia)

  • $ 143
  • Company report
  • May 2013
  • by Euromonitor International

De Jour Sanitary Products is in a precarious situation. As a fading player that primarily competes in tampons, a category that has delivered half a decade of decline, it will over the forecast period be ...

  • Countries : Australia
Cottons Pty Ltd in Tissue and Hygiene (Australia)

Cottons Pty Ltd in Tissue and Hygiene (Australia)

  • $ 143
  • Company report
  • May 2013
  • by Euromonitor International

Cottons differentiates itself from its competitors through its use of natural ingredients. This has been, and will remain, the company’s key point of difference amongst the synthetic products more typical ...

  • Industries : Personal Hygiene
  • Countries : Australia
Emergency Contraception in Australia

Emergency Contraception in Australia

  • $ 992
  • Industry report
  • March 2013
  • by Euromonitor International

Emergency contraception is available in Australia. The product is Schedule 3, which means it can only be sold from behind the counter, involving interaction with a pharmacist. The emergency contraceptive ...

  • Industries : OTC
  • Countries : Australia
Ear Care in Australia

Ear Care in Australia

  • $ 992
  • Industry report
  • March 2013
  • by Euromonitor International

Acute otitis media is an ear infection where ear care products are used to relieve pain, while the growing popularity of swimming and the subsequent incidence of swimmer’s ear represent a key drive ...

  • Industries : OTC
  • Countries : Australia
iNova Pharmaceuticals (Australia) Pty Ltd in Consumer Health (Australia)

iNova Pharmaceuticals (Australia) Pty Ltd in Consumer Health (Australia)

  • $ 143
  • Company report
  • March 2013
  • by Euromonitor International

iNova Pharmaceuticals (Australia) Pty Ltd is focusing on acquiring products and distribution rights to continue its expansion in Australia and in the export markets of New Zealand, the Asia-Pacific region ...

  • Industries : Pharmaceutical
  • Countries : Australia
About 1 900 reports

Download Unlimited Documents from Trusted Public Sources

Therapy Market

  • July 2016
    13 pages
  • Therapy  

  • Australia  

    United States  

    United Kingdom  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.